Article
Comparison of structure and immunogenicity of CVB1-VLP and inactivated CVB1 vaccine candidates
2024-06-28
Abstract excerpt
<title>Abstract</title> <p>Coxsackievirus B1 (CVB1) is a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. In this study, we investigated the immunogenicity of virus-like particle (VLP) and inactivated whole-virus vaccines for CVB1 when administrated to mice via either subcutaneous or intranasal routes formulated wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 516ccdac-2ed0-55ac-ac12-301f8d705b7c
- DOI
- 10.21203/rs.3.rs-4545395/v1
